跳至主要内容
临床试验/NCT03859648
NCT03859648终止不适用

Outcomes in Adults With Mixed or Conductive Hearing Loss Implanted With the BONEBRIDGE

Med-El Corporation6 个研究点 分布在 2 个国家目标入组 9 人开始时间: 2019年8月26日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
9
试验地点
6
主要终点
Number and Proportion of Subjects Experiencing Device Related Adverse Events

研究概览

简要总结

Approximately thirty subjects with mixed or conductive hearing loss, meeting FDA-cleared candidacy criteria for the BONEBRIDGE, will be implanted and followed for three (3) months post-activation to assess safety and effectiveness of the BONEBRIDGE implant.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults, 18 years of age or older at the time of implantation
  • Conductive or mixed hearing loss, defined as:
  • Conductive hearing loss with pure-tone average (PTA) for bone conduction thresholds better than or equal to 25 dB at 500, 1000, 2000 and 3000 Hz
  • Mixed hearing loss with PTA for bone conduction thresholds better than or equal to 45dB at 500, 1000, 2000, and 3000 Hz
  • Air-bone gap greater than or equal to 30 dB at 500, 1000, 2000, and 3000 Hz
  • Ability to benefit from amplification as defined by a monosyllabic (CNC) word score of 30% correct or better
  • Bilateral BONEBRIDGE can be considered if the difference in PTA for bone conduction thresholds is 10 dB or less between the right and left ears
  • Prior experience with acoustic or bone conduction hearing aids, unless candidate is unable to wear amplification for medical reasons
  • Able to complete testing materials in English
  • CT scan indicating the patient's anatomy is adequate to enable placement of the implant
  • Ability to undergo general anesthesia
  • Appropriate motivation and expectation levels
  • Stated willingness to comply with all study procedures for the duration of the study

排除标准

  • Evidence that hearing loss is retrocochlear in origin
  • Skin or scalp condition precluding use of external audio processor
  • Suspected cognitive impairment or organic brain dysfunction

结局指标

主要结局

Number and Proportion of Subjects Experiencing Device Related Adverse Events

时间窗: Up to three (3 months) post activation

Adverse events will be collected and reported throughout the duration of the study.

Percentage Change in AZ Bio Sentence Score in Noise

时间窗: Baseline and 3 months post activation

Percent improvement in AZ Bio sentence in noise scores will be compared from baseline to 3 months post activation.

次要结局

  • Number of Subjects With Stable or Better Soundfield Thresholds(Baseline and 3 months post activation)
  • Number of Subjects With Better QuickSIN Signal-to-noise-ratio Performance(Baseline and 3 months post activation)
  • Percentage Change in CNC Word Score(Baseline and 3 months post activation)
  • Number of Subjects With Stable Unaided Bone Conduction Thresholds(Baseline and 2 weeks post surgery)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验